ID
39922
Beschreibung
Study ID: 110399 Clinical Study ID: 110399 Study Title: A randomized, double blind, parallel group, placebo controlled 28 day study to investigate the safety, tolerability and pharmacodynamics of SB-656933 in subjects with cystic fibrosis. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00903201 https://clinicaltrials.gov/ct2/show/NCT00903201?term=NCT00903201 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: SB656933, Placebo Trade Name: N/A Study Indication: Cystic Fibrosis The study consists of a screening, five study visits and a follow-up (time relative to Baseline in days): Visit 1: Screening, Day -28 to -16 Visit 2a: Day -7 to -4 Visit 2b: Day 1 Visit 3: Day 14 Visit 4: Day 21 Visit 5: Day 28 Visit 6: Early Withdrawal/ Follow-up, Day 35 to 42. From day 1 to day 28 the patients will receive daily doses. This document contains the concomitant medication form. It has to be filled in if concomitant medication has been taken by subject during the study.
Link
https://clinicaltrials.gov/ct2/show/NCT00903201?term=NCT00903201
Stichworte
Versionen (2)
- 25.02.20 25.02.20 -
- 04.03.20 04.03.20 -
Rechteinhaber
GlaxoSmithKline
Hochgeladen am
4. März 2020
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Safety, tolerability and pharmacodynamics of Elubrixin in cystic fibrosis patients, NCT00903201
Concomitant medication
- StudyEvent: ODM
Beschreibung
Concomitant Medication
Alias
- UMLS CUI-1
- C2347852
Beschreibung
Sequence Number
Datentyp
integer
Alias
- UMLS CUI [1]
- C2348184
Beschreibung
(Trade Name preferred)
Datentyp
text
Alias
- UMLS CUI [1,1]
- C2360065
- UMLS CUI [1,2]
- C2347852
Beschreibung
In the original form this item is hidden.
Datentyp
text
Alias
- UMLS CUI [1]
- C2826819
Beschreibung
In the original form this item is hidden.
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0871468
Beschreibung
In the original form this item is hidden.
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C1516698
- UMLS CUI [1,3]
- C0805701
Beschreibung
In the original form this item is hidden.
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0805701
- UMLS CUI [1,2]
- C0231175
Beschreibung
Unit Dose
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0869039
- UMLS CUI [1,2]
- C2347852
Beschreibung
Units of concomitant medication
Datentyp
text
Alias
- UMLS CUI [1,1]
- C1519795
- UMLS CUI [1,2]
- C2347852
Beschreibung
Frequency of concomitant medication
Datentyp
text
Alias
- UMLS CUI [1]
- C2826654
Beschreibung
Route of concomitant medication
Datentyp
text
Alias
- UMLS CUI [1]
- C2826730
Beschreibung
Reason for Medication
Datentyp
text
Alias
- UMLS CUI [1]
- C2826696
Beschreibung
day month year
Datentyp
partialDate
Alias
- UMLS CUI [1]
- C2826734
Beschreibung
00:00-23:59
Datentyp
time
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C1301880
Beschreibung
Concomitant medication prior to study
Datentyp
text
Alias
- UMLS CUI [1]
- C2826667
Beschreibung
If you tick No, please specify End date and time in the appropriate items.
Datentyp
text
Alias
- UMLS CUI [1]
- C2826666
Beschreibung
day month year
Datentyp
partialDate
Alias
- UMLS CUI [1]
- C2826744
Beschreibung
00:00-23:59
Datentyp
time
Alias
- UMLS CUI [1,1]
- C1522314
- UMLS CUI [1,2]
- C2347852
Ähnliche Modelle
Concomitant medication
- StudyEvent: ODM
C2347852 (UMLS CUI [1,2])
C0871468 (UMLS CUI [1,2])
C1516698 (UMLS CUI [1,2])
C0805701 (UMLS CUI [1,3])
C0231175 (UMLS CUI [1,2])
C2347852 (UMLS CUI [1,2])
C2347852 (UMLS CUI [1,2])
C1301880 (UMLS CUI [1,2])
C2347852 (UMLS CUI [1,2])
Keine Kommentare